Clinical Trials Browser

Lymphoma, Follicular, Waldenstrom Macroglobulinemia, Recurrence, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Hematologic Neoplasms, Lymphoma, Mantle-Cell

NCT07416695 2026-02-18

A Phase I Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of HLX3901 in Patients With Advanced SCLC or NEC

Phase 1 Not yet recruiting

138 enrolled

Thoracic

SCLC

NCT07414836 2026-02-17

A First-in-Human Study of BG-C0979 in Adults With Advanced Solid Tumors

Phase 1 Not yet recruiting

84 enrolled

Other solid neoplasm

Advanced Solid Tumor

NCT07414953 2026-02-17

A Phase Ib Study of HS-10504 Combined Therapy in NSCLC

Phase 1 Not yet recruiting

400 enrolled

Thoracic

Lung Neoplasms

NCT07408258 2026-02-13

Safety, Pharmacokinetics (PK), and Efficacy of ONC-783 in Advanced Solid Tumors

Phase 1 Not yet recruiting

20 enrolled

Other solid neoplasm

Advanced Solid Tumor

NCT07409246 2026-02-13

A Study to Evaluate the, Adverse Events, Change in Disease Activity, Tolerability, and How Intravenous ABBV-438 Moves Through the Body in Adult Participants With Multiple Myeloma (MM)

Phase 1 Not yet recruiting

127 enrolled

Plasma cell

Multiple Myeloma, Neoplasms

NCT07407504 2026-02-12

GenSci145 as Monotherapy or in Combination Therapy, in Participants With PIK3CA-mutated, Locally Advanced or Metastatic Solid Tumors.

Phase 1 Not yet recruiting

186 enrolled

Other solid neoplasm

Locally Advanced or Metastatic Solid Tumors With PIK3CA-mutated

NCT07400744 2026-02-10

A Study to Compare the PK , Safety, and Immunogenicity of QL2109 With Daratumumab in Male Subjects

Phase 1 Not yet recruiting

102 enrolled

Plasma cell

Multiple Myeloma

NCT07395258 2026-02-09

A Study to Test Different Doses of BI 3923948 Alone and in Combination With an Anti-PD-1 Antibody in People With Different Types of Advanced Cancer (Solid Tumors)

Phase 1 Not yet recruiting

60 enrolled

Other solid neoplasm

Solid Tumors

NCT07391644 2026-02-06

A Study of JSKN027 in Patients With Advanced Solid Tumors

Phase 1 Not yet recruiting

250 enrolled

Other solid neoplasm

Advanced Malignant Solid Tumor

NCT07383506 2026-02-03

A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors

Phase 1 Not yet recruiting

90 enrolled

BreastGynecologic

Breast Neoplasms, Endometrial Neoplasms

NCT07380334 2026-02-02

A Clinical Study on the Safety, Tolerability, Pharmacokinetics and Efficacy of SHR-1049 in Patients With Advanced Solid Tumors

Phase 1 Not yet recruiting

200 enrolled

Other solid neoplasm

Advanced Solid Tumor

Clinical Trials

Clinical Trial of TQB3205 Capsule in Subjects With Advanced Malignant Tumors

JL19001-NMIBC

Study of GB-4362 With Enfortumab Vedotin and Pembrolizumab for Advanced Urothelial Cancer

A Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1189 in Healthy Adults 18 to 30 Years of Age

Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of HLX97 (a KAT6A/B Inhibitor) in Patients With Advanced/Metastatic Solid Tumor

A First-In-Human Phase I/IIa Study to Evaluate DA 3501 in Patients With Advanced Gastric or Gastro-esophageal Junction Adenocarcinoma and Pancreatic Ductal Adenocarcinoma

A Phase 1 Study of D3S-003 as Monotherapy in Participants With Advanced Solid Tumors With a KRAS p.G12D Mutation.

Pharmacokinetics, Safety, and Immunogenicity Comparison of Bmab1700 and Opdivo® as Adjuvant Monotherapy in Participants With Melanoma

A Study to Compare the PK Characteristics, Safety, Tolerability, and Immunogenicity of HLX15-SC With DARZALEX FASPRO® in Combination With Lenalidomide and Dexamethasone (Rd) in Transplant-ineligible Patients With Newly Diagnosed Multiple Myeloma

A Study to Investigate CEA-PRIT 2.0 in Participants With Metastatic Colorectal Cancer (mCRC)

A Phase 1 Study of the Safety and Tolerability of CTX-10726

A Study on the Novel Oncolytic Virus Combined With PD-1 Inhibitor in the Treatment of Recurrent High-grade Glioma

JSKN016HC in Patients With Advanced or Metastatic Solid Malignant Tumors

A Phase 1 Clinical Study to Evaluate the Safety and Efficacy of WSK-IM02 in Patients With Platinum-resistant Recurrent Ovarian Cancer.

A Phase 1 Study of PRT12396 in Participants With Select Myeloproliferative Neoplasms

IMFINZI-subQ

An Open-Label Study to Evaluate PF-07994525 in Participants With Advanced Cancers

QLS5212 for Participants With Advanced Solid Tumors

A Phase I Clinical Study of GLR2037 in Patients With Advanced Prostate Cancer

A Phase 1 Safety and Dose Finding Study of GLIX1 in Adults With Recurrent or Progressive High-grade Glioma

A Study Evaluating the Safety and Efficacy of KITE-363 in Relapsed/Refractory Autoimmune Neurologic Diseases

A Phase 1 Study of EPI-326 in EGFR-mutant NSCLC and HNSCC

Study of QLS5308 in Patients With Advanced Solid Tumors

A Mass Balance Study of DZD8586 in Healthy Male Participants (TAI-SHAN15)

A Phase I Study of FZ-AD005 in Patients With High-Grade Glioma (HGG)

Study of ABO2102 in KRAS-Mutated Solid Tumors

BAF_FRontier-1

Study of ZG006 in Combination With PD-1/PD-L1 Immune Checkpoint Inhibitors as First-Line Standard Therapy in Participants With Extensive Stage Small-Cell Lung Cancer

First-in-Human Study of ADCE-B05 in Patients With Advanced Solid Tumors

A Study of BGM-2121 in Patients With Advanced Solid Tumors

A Study to Assess a Medicine Called Tovorafenib in Japanese Children and Young Adults With Brain Tumours

A Study to Test How Well Different Doses of BI 1831169 in Combination With an Anti-PD1 Antibody Are Tolerated in Japanese People With Different Advanced Cancers

HWS116 Monotherapy in Patients With Advanced Solid Tumors

First Time in Human (FTIH) Study to Investigate the Safety and Preliminary Activity of GSK5533524 Alone or in Combination in Adult Participants With Advanced Solid Tumors

DUNP19

Evaluation of T320, an Anti-Tissue Factor Antibody-Drug Conjugate, in Patients With Advanced Solid Tumors

Pharmacokinetics and Safety Study of Pelabresib in Patients With Advanced Malignancies and Hepatic Impairment

A Study of ITC-6146RO in Patients With Advanced or Metastatic Cancer Who Have Failed Standard Therapy

A Study of APG-3288 in Relapsed/Refractory Blood Cancers

A Phase I Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of HLX3901 in Patients With Advanced SCLC or NEC

A First-in-Human Study of BG-C0979 in Adults With Advanced Solid Tumors

A Phase Ib Study of HS-10504 Combined Therapy in NSCLC

Safety, Pharmacokinetics (PK), and Efficacy of ONC-783 in Advanced Solid Tumors

A Study to Evaluate the, Adverse Events, Change in Disease Activity, Tolerability, and How Intravenous ABBV-438 Moves Through the Body in Adult Participants With Multiple Myeloma (MM)

GenSci145 as Monotherapy or in Combination Therapy, in Participants With PIK3CA-mutated, Locally Advanced or Metastatic Solid Tumors.

A Study to Compare the PK , Safety, and Immunogenicity of QL2109 With Daratumumab in Male Subjects

A Study to Test Different Doses of BI 3923948 Alone and in Combination With an Anti-PD-1 Antibody in People With Different Types of Advanced Cancer (Solid Tumors)

A Study of JSKN027 in Patients With Advanced Solid Tumors

A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors

A Clinical Study on the Safety, Tolerability, Pharmacokinetics and Efficacy of SHR-1049 in Patients With Advanced Solid Tumors